Medicines watchdog battles to reinstate chief
by Gary Finnegan: The European Medicines Agency is waging a fierce battle against the EU’s own employment court over the controversial 2011 appointment of its former Executive Director.
by Gary Finnegan: The European Medicines Agency is waging a fierce battle against the EU’s own employment court over the controversial 2011 appointment of its former Executive Director.
by Gary Finnegan: The European Medicines Agency wants to get new medicines to patients quicker where there is a clear unmet medical need. The move could also see… read more.
by Gary Finnegan: The European Medicines Agency’s influential Committee for Medicinal Products for Human Use (CHMP) has given the green light for ten new medicines, as well as offering… read more.
A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.
A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.
by Bruce Sylvester: Menopausal women having difficulty with time management, attention, organization, memory, and problem solving (also known as “executive functions”) appear to benefit from treatment with lisdexamfetamine,… read more.
by Bruce Sylvester: Rociletinib, an investigative therapy for treatment resistant EGFR-mutation driven lung tumors, shows activity against the most common resistance mutation, and it significantly improves clinical outcomes.
by Gary Finnegan: Keytruda (pembrolizumab) has been recommended by the European Medicines Agency (EMA) as monotherapy for the treatment of adult patients with advanced melanoma that cannot be… read more.
by Gary Finnegan: Patients whose high cholesterol cannot be controlled by currently available therapies are set to have a new treatment option.
by Gary Finnegan: Survival rates in young patients with high-risk neuroblastoma can be improved by Unituxin (dinutuximab), a new treatment approved by the European Medicines Agency (EMA).
Research published today in the journal Analyst has demonstrated a new, noninvasive test that can detect cocaine use through a simple fingerprint. For the first time, this new fingerprint method… read more.
by Gary Finnegan: Canada could save $7.3 billion annually with universal public coverage of medically necessary prescription drugs, according to new research from the University of British Columbia… read more.